Terms: = Thyroid cancer AND CTCF, P49711, 10664, ENSG00000102974 AND Prognosis
2 results:
1. LncRNA EILA promotes CDK4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
Cai Z; Shi Q; Li Y; Jin L; Li S; Wong LL; Wang J; Jiang X; Zhu M; Lin J; Wang Q; Yang W; Liu Y; Zhang J; Gong C; Yao H; Yao Y; Liu Q
Sci Adv; 2023 Oct; 9(40):eadi3821. PubMed ID: 37801505
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Zhang L; Sun S; Zhao X; Liu J; Xu Y; Xu L; Song C; Li N; Yu J; Zhao S; Yu P; Fang F; Xie J; Ji X; Yu R; Ou Q; Zhao Z; Li M
Mol Oncol; 2022 Oct; 16(20):3689-3702. PubMed ID: 35971249
[TBL] [Abstract] [Full Text] [Related]
